LooperVerse Review – Paused for Orders, and Three Months From a Federal Ban

Read This First: The Store Is Paused

We do not know why the pause is in place, and we are not going to guess. It could be inventory, a platform migration, a payment processor, a supply issue or a regulatory decision. The company has not said, and inventing a reason would be worse than admitting we do not have one.

What we can say is that a review that told you to go and sign up today would be wrong, so this one does not. If you have a pending order, the company says it is still processing those. If you were planning a first purchase, there is nothing to buy at the moment and a deadline worth understanding before there is.

The 12 November 2026 Deadline

This is the most important thing on this page and it applies to the whole category, not just to this brand.

Legal analysts have estimated this standard would render roughly 95% of existing hemp-derived cannabinoid products federally unlawful.

Now look at what LooperVerse sells: HHC, HHC-P, THC-P, THC-A, delta-8 and delta-9. That is a catalogue composed almost entirely of the compounds the statute names. The THCA pre-rolls are the clearest illustration — those products exist as “hemp” only because the current threshold ignores THCA, and the new definition counts it.

We are describing the statute as written and its stated effective date. We are not predicting how enforcement will run, whether litigation will alter it, or what any individual company will do — all of which remain open. But as of today that is roughly three months away, and anyone deciding whether to build a habit around these products should know it.

What LooperVerse Is and Who It Is For

LooperVerse — the brand is also styled simply Looper — is a US seller of intoxicating hemp-derived cannabinoid products: vape cartridges, disposables, pre-rolls, gummies and a delta-9 soda. The site is gated at “YOU MUST BE 21+ TO ENTER”, and its FAQ states “21+ only. We verify age before purchase.”

It is worth being plain about what this is, because the advertiser’s own description — which talks about travelling deep into a dimension and a zero gravity environment delivering ultimate lifting effects — is marketing copy that describes nothing. In practical terms these are recreational intoxicants sold through the hemp channel, aimed at adults who want cannabis-type effects in states or situations where cannabis itself is not available to them.

They are not wellness products, not supplements in any meaningful sense, and not a weight-management aid. We mention that last point because this is a weight-loss site: cannabinoid products are widely associated with increased appetite, so if you arrived here from that direction, this category works against you rather than for you.

The Catalogue and What Is Actually In It

Products and prices observed on the site on 7 August 2026. Note how many distinct cannabinoids appear in single products.

The gummy is the one to look at twice. Four different cannabinoids in one product — delta-8, delta-9, HHC and THC-A — is a combination for which there is no meaningful human research on the interaction. That is not a claim that it is dangerous; it is a statement that nobody can tell you what the combined effect profile is, because it has not been studied.

What the Research Says About HHC-P

HHC-P (hexahydrocannabiphorol) has its own product category here, so it deserves a proper look rather than a hand-wave.

A 2025 in vitro study published in Drug Testing and Analysis examined CB1 receptor activation by HHC, HHC-O and HHC-P. It found (9R)-HHC-P acts as a partial agonist at CB1 with roughly two-fold lower potency than JWH-018, with the (S)-epimer less potent again. JWH-018 is a first-generation synthetic cannabinoid of the type found in “spice” products and associated with serious adverse effects — so being within a factor of two of it is the relevant context, not a reassurance.

There is also a published case report describing long-lasting cognitive and physical impairment after recreational use of HHC-C9, a related semi-synthetic cannabinoid. To be precise: HHC-C9 is not HHC-P, and a single case report is not evidence of a general effect. We include it because it illustrates the actual state of knowledge in this class — the safety literature currently consists largely of case reports and in vitro work, not the controlled human trials you would want before inhaling something regularly.

The practical upshot: dose unpredictability is the main hazard. When labelling is inconsistent across batches and the compound is potent, the same product bought twice may not behave the same way. Start far lower than you think you need, and never combine with alcohol or drive.

Pricing and the All-In Cost

There are no subscriptions, tiers or consultation fees here — it is straightforward retail, with observed prices of $24.99 to $39.99 for most items and the soda from $7.50. There is a military discount page.

We could not establish an all-in cost, because shipping charges are not published on the pages we could read. Fulfilment is stated as 1–2 business days to process and typically 3–7 business days to arrive. We are not going to estimate a delivery charge we could not find.

Eligibility, State Restrictions and Drug Testing

21+ only, gated at entry, with the company stating it verifies age before purchase. Sales are US-only.

On state law, the company states that its products “comply with the 2018 Farm Bill, but some states restrict sales” and advises checking its shipping policy. We could not find a published list of excluded states on the pages we could read, which is a real gap — state law on intoxicating hemp varies enormously and several states have banned these compounds outright. Do not treat a website’s willingness to display a product as evidence that it is lawful where you live.

Who should not use these products at all:

• Anyone under 21.
• Anyone who is pregnant or breastfeeding.
• Anyone who will drive or operate machinery — see the road safety finding above.
• Anyone subject to drug testing of any kind.
• Anyone with a personal or family history of psychosis or serious mental illness.
• Anyone with a significant cardiac condition.
• Anyone taking prescription medication, without speaking to their prescriber first.

Common effects associated with cannabinoid products include impaired coordination and concentration, dry mouth, raised heart rate, and — at higher doses — anxiety, paranoia, disorientation, nausea and vomiting. With potent semi-synthetics and inconsistent labelling, the risk of reaching that higher-dose territory unintentionally is the specific concern.

Legitimacy, Testing and Oversight

There is no licensing or accreditation regime for this category comparable to pharmacy or medical licensure. Nothing sold here is FDA-approved, and the site carries the standard disclaimer that products are “not intended to diagnose, treat, cure or prevent any disease”. There is no regulator whose database you can check a licence number against, because there are no licence numbers to check.

What the company does provide is published certificates of analysis, with dedicated COA and lab-report sections on the site. Third-party testing with publicly posted results is the single most meaningful signal available in an unregulated category, and its presence here is a genuine point in the brand’s favour — as is the fact that the results are organised by year rather than buried.

We should be careful not to overstate that, though. We did not audit individual certificates against individual batches, which is the step that actually establishes whether published testing means anything. And published COAs do not address the class-wide finding that content varies between batches — they address whether a given tested batch matched its label.

There Are No Returns

So the only route to a refund is damage or defect. If you dislike the flavour, find the potency wrong, or react badly, that is your money spent. For inhalables and ingestibles this is a common and defensible policy on hygiene grounds — but combined with a product class the research describes as inconsistent between batches, it means the risk of an unpredictable product sits entirely with the buyer. Buy one item before buying several.

How It Compares

The useful comparison is not against other intoxicating hemp brands — they largely share the same legal exposure and the same evidence gap — but against the alternatives a buyer actually has.

The honest conclusion: if you live somewhere cannabis is legally available, a licensed dispensary beats this on every axis that matters — actual regulatory oversight, mandated testing, enforceable labelling and no federal deadline hanging over it. The intoxicating hemp channel exists primarily to serve people who do not have that option, and it is that constituency the November change will affect most.

Pros and Cons

Who Should Consider It, and Who Should Not

Nobody should be signing up today, for the simple reason that the store is not taking orders. If and when that changes, the realistic candidate is an adult over 21, in a state that permits these compounds, who already uses cannabinoid products knowingly, wants published COAs, and understands that the category faces a federal deadline in November.

Look elsewhere if you have a licensed dispensary available — it is better on oversight, testing and labelling, and it is not on a clock. Look elsewhere if you are new to cannabinoids entirely, because a potent semi-synthetic with inconsistent batch labelling is the worst possible starting point. And look elsewhere if you are subject to drug testing, since the company itself tells you these will show up.

If you came here from a weight-loss search, this is not for you. There is no evidence base for cannabinoid products in weight management, they are associated with increased appetite, and nothing here has been studied alongside GLP-1 medications. That is a conversation for your prescriber, not a purchase.

Limitations of This Review

We have not purchased or used any LooperVerse product, and could not have during the order pause. We did not test any product independently or audit individual certificates of analysis against individual batches — so we can confirm that COAs are published, not that they are accurate.

Specific gaps: we do not know why the store is paused or when it will reopen, and we have not speculated. We could not locate a published list of restricted states or any shipping cost, so no all-in figure is given. We found no substantial independent customer-review body — no Trustpilot or BBB record we could read — so this review carries no customer satisfaction score and no complaint data. Company details are as published on the site on 7 August 2026 and may change, particularly given the pause.

On the law: we have described P.L. 119-37 as enacted and its stated effective date. Regulatory implementation, enforcement priorities and any litigation remain open questions, and this is not legal advice — nor is any of it medical advice. State law varies and changes; verify your own position before buying anything in this category.

Frequently Asked Questions

Verdict

The score is low, and it is worth being clear that it is not a judgement on the company’s honesty. On several measures LooperVerse behaves better than its competitors: it publishes certificates of analysis in an organised, findable section, it gates access at 21+, it concedes that state restrictions exist, and it answers the drug-testing question in one direct sentence where most brands in this space will not answer it at all. Those things count.

But a review has to serve the reader in front of it, and that reader is trying to decide whether to buy. Today they cannot: the site says it is not accepting new orders. When they can, they will be buying into a category with no returns, no published state list, no published shipping cost, and no established safety profile for its headline compound — a semi-synthetic that in vitro sits within a factor of two of JWH-018 on CB1 potency, in a class the literature describes as frequently mislabelled and inconsistent between batches.

And behind all of it is 12 November 2026. The Continuing Appropriations Act, 2026 redefines hemp to count THCA toward the 0.3% limit, caps products at 0.4 mg of THC, and names synthetic and unnatural cannabinoids including delta-8 and HHC. That is the entire LooperVerse catalogue described in a single sentence of statute, roughly three months from now. Whatever happens to this particular brand, that deadline is the fact worth carrying away from this page — and if you want cannabinoids with actual regulatory oversight behind them, a state-licensed dispensary is the better answer in every respect.